Author

L. Testa

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

The impact of axillary lymph node dissection on the indication of adjuvant abemaciclib in high-risk hormone receptor-positive breast cancer: real-world analysis from a multicenter cohort in Brazil

Introduction: Adjuvant abemaciclib combined with endocrine therapy improves outcomes in patients with high-risk, hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. Lymph node involvement is a key determinant of recurrence risk and treatment decisions. However,...

L. Holland, L. Testa, C. Cavalcanti et al. · Mastology · 0 citations

Open access 2026

Predictors of four versus six cycles of adjuvant docetaxel–cyclophosphamide in hormone receptor-positive early breast cancer

Introduction: Docetaxel and cyclophosphamide (TC) are a commonly used anthracycline-free regimen for hormone receptor-positive (HR+) early-stage breast cancer. Although typically administered for four to six cycles, the optimal number remains uncertain. Objective: To identify clinical and pathological factors associat...

W. Lima, Rafaela Lopes da Silva Naves, R. Bonadio et al. · Mastology · 0 citations